Policy alternatives for treatments for rare diseases.
Panju
Abbas H
AH
DeGroote School of Business, McMaster University, Hamilton, Ont.
Bell
Chaim M
CM
D002170:Canada / Q000453:epidemiology; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D006291:Health Policy / Q000331:legislation & jurisprudence; D006801:Humans; D009965:Orphan Drug Production / Q000191:economics / Q000331:legislation & jurisprudence; D011050:Policy Making; D035583:Rare Diseases / Q000188:drug therapy* / Q000453:epidemiology; D012042:Registries